How many institutions held IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in Q2 2022?

124 institutional investors reported IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

Q: What does CUSIP 45256X103 represent in this 13F holders report?

CUSIP 45256X103 is the security identifier for IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 45256X103

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 1,124,549,707
Total 13F shares: 33,071,782
Share change: -2,424,263
Total reported value: $123,053,543
Put/Call ratio: 225%
Price per share: $3.72
Number of holders: 124
Value change: -$11,174,770
Number of buys: 69
Number of sells: 55

Quarterly Holders Quick Answers

What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 45256X103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	0.64%	7,156,146	$40,146,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.6%	6,760,306	$37,925,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	0.45%	5,112,873	$28,683,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.14%	1,548,015	$8,684,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.11%	1,189,163	$6,671,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.1%	1,073,506	$6,023,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.07%	780,200	$4,377,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	764,940	$4,291,000	—	31 Mar 2022	13F
ALLEN HOLDING INC /NY	13F	Company	0.06%	687,571	$3,857,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.06%	667,370	$3,745,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.05%	610,089	$3,423,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	493,059	$2,767,000	—	31 Mar 2022	13F
CREDIT SUISSE AG/	13F	Company	0.04%	457,468	$2,566,000	—	31 Mar 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.04%	412,541	$2,314,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	408,175	$2,290,000	—	31 Mar 2022	13F
ORACLE INVESTMENT MANAGEMENT INC	13F	Company	0.04%	400,013	$2,244,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.03%	393,004	$2,205,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.03%	342,778	$1,923,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	339,861	$1,907,000	—	31 Mar 2022	13F
HARBOURVEST PARTNERS LLC	13F	Company	0.03%	335,709	$1,883,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	278,720	$1,564,000	—	31 Mar 2022	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.02%	196,200	$1,156,000	—	31 Mar 2022	13F
SHEETS SMITH WEALTH MANAGEMENT	13F	Company	0.02%	203,876	$1,144,000	—	31 Mar 2022	13F
Vident Investment Advisory, LLC	13F	Company	0.02%	201,588	$1,131,000	—	31 Mar 2022	13F
John C. Thomas	3/4/5	Former Director	— class O/S missing	216,363	$1,086,143	—	31 Dec 2021	3/4/5
Swiss National Bank	13F	Company	0.02%	188,000	$1,055,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	186,058	$1,044,000	—	31 Mar 2022	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.02%	177,326	$995,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.02%	173,030	$971,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.01%	165,121	$926,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.01%	153,282	$861,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	149,606	$840,000	—	31 Mar 2022	13F
Clearwater Capital Advisors, LLC	13F	Company	0.01%	147,891	$830,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	133,280	$748,000	—	31 Mar 2022	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.01%	120,665	$711,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.01%	124,998	$701,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.01%	123,902	$695,000	—	31 Mar 2022	13F
Advisory Services Network, LLC	13F	Company	0.01%	113,299	$636,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.01%	109,434	$614,000	—	31 Mar 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.01%	100,861	$565,832	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	96,869	$543,000	—	31 Mar 2022	13F
MERIDIAN INVESTMENT COUNSEL INC.	13F	Company	0.01%	96,433	$541,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.01%	95,268	$534,000	—	31 Mar 2022	13F
CITIGROUP INC	13F	Company	0.01%	93,172	$523,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	88,123	$494,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.01%	86,500	$485,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.01%	83,204	$467,000	—	31 Mar 2022	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.01%	64,030	$359,000	—	31 Mar 2022	13F
Winning Points Advisors, LLC	13F	Company	0.01%	60,126	$339,000	—	31 Mar 2022	13F
Stonehage Fleming Financial Services Holdings Ltd	13F	Company	0.01%	60,000	$336,000	—	31 Mar 2022	13F

Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q2 2022

As of 30 Jun 2022, ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by 124 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,071,782 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and CREDIT SUISSE AG/. This page lists 124 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

135

Q2 2022 holders

124

Holder diff

-11

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.